Eris Lifesciences Limited — Others, 20-03-2025: Spurt in Volume

Eris Lifesciences has responded to the National Stock Exchange regarding the significant increase in share volumes, clarifying that all relevant material information has been disclosed in accordance with regulation requirements. The company asserts that there are no pending announcements affecting the security's price or volume, attributing the surge solely to market dynamics. This response reinforces the company’s transparency and proactive communication with shareholders. Investors may view this as a neutral impact, suggesting that fluctuations are market-driven rather than stemming from company-specific news.